Tag Archives: Alexion Pharmaceuticals

Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013

By Business Wirevia The Motley Fool

Filed under:

Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013

CHESHIRE, Conn.–(BUSINESS WIRE)– Alexion Pharmaceuticals, Inc. (NAS: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2013 on Thursday, April 25, 2013 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio web cast on Thursday, April 25, 2013, at 10:00 a.m. Eastern Time (ET).

To participate in this conference call, dial 888-312-3051 (USA) or 719-325-2168 (International), passcode 7274940 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 7274940. The audio web cast can be accessed at: www.alexionpharma.com.

[ALXN-G]

Alexion Pharmaceuticals, Inc.
Irving Adler, 203-271-8210
Executive Director
Corporate Communications
or
(Media)
Alexion Pharmaceuticals, Inc.
Kim Diamond, 203-439-9600
Senior Director, Corporate
Communications
or
(Investors)
Rx Communications
Rhonda Chiger, 917-322-2569

KEYWORDS:   United States  North America  Connecticut

INDUSTRY KEYWORDS:

The article Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
} else if (obj.attachEvent){
var r = obj.attachEvent("on"+evType, fn);

From: http://www.dailyfinance.com/2013/04/11/alexion-pharmaceuticals-to-report-first-quarter-20/

Here's What This $14 Billion Hedge Fund Company Has Been Buying

By Selena Maranjian, The Motley Fool

Filed under:

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a bright light on smart stock picks.

Today, let’s look at Viking Global Investors, founded in 1999 by Andreas Halvorsen and David Ott, who had previously worked together at Julian Robertson‘s respected Tiger Management firm. Viking is known as a long-short global equity fund, meaning that it aims to maintain long positions in companies on which it’s bullish and short positions in those where it’s bearish.

The company’s reportable stock portfolio totaled $14.4 billion in value as of Dec. 31, 2012.

Interesting developments
So what does Viking’s latest quarterly 13F filing tell us? Here are a few interesting details:

The biggest new holdings are Alexion Pharmaceuticals and Las Vegas Sands. Other new holdings of interest include EMC and TIBCO Software . EMC is a $50 billion storage giant, with solid growth prospects in the rapidly growing cloud-computing and Big Data arenas. It also holds an 80% ownership stake in virtualization specialist VMware. EMC has been held back some by softness in technology spending due to a weak global economy, but that won’t last forever. In the meantime, it has struck a partnership with Lenovo, which might help it in China, and its recent earnings report was solid, with strong operating income growth

TIBCO is another Big Data operator, and one that got whacked late last year after posting disappointing earnings results. It had previously posted a long string of strong earnings and pointed to softness in orders as well as some weather interference for the miss. Still, management is upbeat, as are some of my colleagues, such as Anders Bylund, who bought shares. Some think the company may end up acquired by another.

Among holdings in which Viking Global increased its stake was BlackBerry . BlackBerry, until very recently known as Research In Motion, has been fighting strong competition from iPhones and Android devices. (Apple, for example, is expected to debut a lower-cost smartphone that might appeal to businesses that buy in bulk for employees, threatening BlackBerry’s longtime strength in the corporate market.) BlackBerry recently debuted some new devices, but some think that’s not enough to turn the company around.

Viking Global reduced its stake in lots of companies, including Sherwin-Williams , which has averaged annual growth of nearly 30% over the past five years, partly on signs of a housing market recovery. Last year, the company bought global paint giant Comex, based in Mexico, for $2.3 billion. Some don’t like that the deal will add to Sherwin-Williams’ debt, but others see it as a smart strategic move. In a sign of strength, the company recently boosted its dividend by 28%. With a forward P/E ratio of 19, it’s reasonable to see the stock as not a bargain right now.

Finally, Viking’s biggest closed positions included Apple and priceline.com. Other closed positions of …read more
Source: FULL ARTICLE at DailyFinance

Alexion to Present at the Barclays Global Healthcare Conference

By Business Wirevia The Motley Fool

Filed under:

Alexion to Present at the Barclays Global Healthcare Conference

CHESHIRE, Conn.–(BUSINESS WIRE)– Alexion Pharmaceuticals, Inc. (NAS: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Barclays Global Healthcare Conference in Miami at 10:45 a.m. Eastern time on Tuesday, March 12, 2013.

An audio webcast of Mr. Sinha’s remarks will be available live. You can access the webcast at: www.alexionpharma.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

[ALXN-G]

Alexion Pharmaceuticals, Inc.
Irving Adler, 203-271-8210
Executive Director, Corporate Communications
or
Media:
Alexion Pharmaceuticals, Inc.
Kim Diamond, 203-439-9600
Director, Corporate Communications
or
Investors:
Rx Communications
Rhonda Chiger, 917-322-2569

KEYWORDS:   United States  North America  Connecticut  Florida

INDUSTRY KEYWORDS:

The article Alexion to Present at the Barclays Global Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
} else if (obj.attachEvent){
var r = obj.attachEvent("on"+evType, fn);
return r;
}
}

addEvent(window, "load", function(){new FoolVisualSciences();})
addEvent(window, "load", function(){new PickAd();})

var themeName = 'dailyfinance.com';
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-24928199-1']);
_gaq.push(['_trackPageview']);

(function () {

var ga = document.createElement('script');
ga.type = 'text/javascript';
ga.async = true;
ga.src = ('https:' …read more
Source: FULL ARTICLE at DailyFinance